Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05088226 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

StatusRecruiting
PhasePhase 2
Started2021-12-01
View on ClinicalTrials.gov ↗

Amendment history

2026-04-22
Study Status v1
Primary completion date2022-06-01→2030-06-01
Completion date2023-06-01→2031-06-01
2021-10-20
Original filing
The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Chidamide intensified conditioning regimen in patients with Acute B cell Lymphoblast leukemia Underwenting Haploidenticl Peripheral blood Stem Cell Transplantation.
Trial Details
NCT Number NCT05088226
Lead Sponsor Chinese PLA General Hospital
Conditions Peripheral Blood Stem Cell Transplantation
Enrollment 50 participants
Start Date 2021-12-01
Primary Completion 2030-06-01 (estimated)
Study Completion 2031-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-23